Back to Search Start Over

Precision medicine in breast cancer: reality or utopia?

Authors :
Jingxuan Shan
François Ghiringhelli
Stéphanie Plenchette
Ali Bettaieb
Lotfi Chouchane
Catherine Paul
Laboratoire d'Immunologie et d'Immunothérapie des cancers [Dijon] ( LIIC )
École pratique des hautes études ( EPHE ) -Université de Bourgogne ( UB ) -Université Bourgogne Franche-Comté ( UBFC )
Weill Cornell Medical College in Qatar
Lipides - Nutrition - Cancer [Dijon - U1231] ( LNC )
Université de Bourgogne ( UB ) -AgroSup Dijon - Institut National Supérieur des Sciences Agronomiques, de l'Alimentation et de l'Environnement-Institut National de la Santé et de la Recherche Médicale ( INSERM )
Laboratoire d'Immunologie et d'Immunothérapie des cancers [Dijon] (LIIC)
École pratique des hautes études (EPHE)
Université Paris sciences et lettres (PSL)-Université Paris sciences et lettres (PSL)-Université Bourgogne Franche-Comté [COMUE] (UBFC)-Université de Bourgogne (UB)
Weill Cornell Medicine [Qatar]
Lipides - Nutrition - Cancer [Dijon - U1231] (LNC)
Université de Bourgogne (UB)-Institut National de la Santé et de la Recherche Médicale (INSERM)-AgroSup Dijon - Institut National Supérieur des Sciences Agronomiques, de l'Alimentation et de l'Environnement
Source :
Journal of Translational Medicine, Journal of Translational Medicine, BioMed Central, 2017, 15 (1), pp.139. 〈https://translational-medicine.biomedcentral.com/articles/10.1186/s12967-017-1239-z〉. 〈10.1186/s12967-017-1239-z〉, Journal of Translational Medicine, BioMed Central, 2017, 15 (1), pp.139. ⟨10.1186/s12967-017-1239-z⟩, Journal of Translational Medicine, Vol 15, Iss 1, Pp 1-13 (2017)
Publication Year :
2017
Publisher :
Springer Science and Business Media LLC, 2017.

Abstract

International audience; Many cancers, including breast cancer, have demonstrated prognosis and support advantages thanks to the discovery of targeted therapies. The advent of these new approaches marked the rise of precision medicine, which leads to improve the diagnosis, prognosis and treatment of cancer. Precision medicine takes into account the molecular and biological specificities of the patient and their tumors that will influence the treatment determined by physicians. This new era of medicine is accessible through molecular genetics platforms, the development of high-speed sequencers and means of analysis of these data. Despite the spectacular results in the treatment of cancers including breast cancer, described in this review, not all patients however can benefit from this new strategy. This seems to be related to the many genetic mutations, which may be different from one patient to another or within the same patient. It comes to give new impetus to the research-both from a technological and biological point of view-to make the hope of precision medicine accessible to all.

Details

ISSN :
14795876
Volume :
15
Database :
OpenAIRE
Journal :
Journal of Translational Medicine
Accession number :
edsair.doi.dedup.....d26c4fc95b1efb701eddc328e1b4fb16